Article
Multiple assays in a real-time RT-PCR SARS-CoV-2 panel can mitigate the risk of loss of sensitivity by new genomic variants during the COVID-19 outbreak.
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases - 1 Aug 2020
Peñarrubia Luis, Ruiz Maria, Porco Roberto, Rao Sonia N, Juanola-Falgarona Martí, Manissero Davide, López-Fontanals Marta, Pareja Josep
Abstract excerpt
OBJECTIVES: In this study, five SARS-CoV-2 PCR assay panels were evaluated against the accumulated genetic variability of the virus to assess the effect on sensitivity of the individual assays. DESIGN OR METHODS: As of week 21, 2020, the complete set of available SARS-CoV-2 genomes from GISAID and GenBank databases were used in this study. SARS-CoV-2 primer sequences from publicly available panels (WHO, CDC,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
